Notice of Knight Therapeutics' Fourth Quarter and Year End 2022 Results Conference Call Pharmaceutical Investing
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature Pharmaceutical Investing
BriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual Meeting Pharmaceutical Investing
Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments Pharmaceutical Investing
Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint Life Science Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics , Seagen Inc. , Provention Bio Inc. , Kimball International, Inc. Pharmaceutical Investing
AbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting Pharmaceutical Investing
